Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Nomura, Kyoichi"" wg kryterium: Autor


Tytuł:
Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration.
Autorzy:
Tahara M; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan. Electronic address: .
Oeda T; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan.
Okada K; Department of Neurology, University of Occupational and Environmental Health, Kitakyushu, Japan.
Ochi K; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Maruyama H; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Fukaura H; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
Nomura K; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
Shimizu Y; Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Nakashima I; Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Misu T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Umemura A; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan.
Yamamoto K; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan.
Sawada H; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan.
Pokaż więcej
Źródło:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2022 Apr; Vol. 60, pp. 103730. Date of Electronic Publication: 2022 Mar 07.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Neuromyelitis Optica*/chemically induced
Neuromyelitis Optica*/drug therapy
Compassionate Use Trials ; Humans ; Immunologic Factors/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Prospective Studies ; Rituximab/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration.
Autorzy:
Tahara, Masayuki
Oeda, Tomoko
Okada, Kazumasa
Ochi, Kazuhide
Maruyama, Hirofumi
Fukaura, Hikoaki
Nomura, Kyoichi
Shimizu, Yuko
Nakashima, Ichiro
Misu, Tatsuro
Umemura, Atsushi
Yamamoto, Kenji
Sawada, Hideyuki
Pokaż więcej
Źródło:
Multiple Sclerosis & Related Disorders; Apr2022, Vol. 60, pN.PAG-N.PAG, 1p
Czasopismo naukowe
Tytuł:
Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled study.
Autorzy:
Hatano T; Department of Neurology, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, 113-8421, Tokyo, Japan. .
Kano O; Department of Neurology, Faculty of Medicine, Toho University, 6-11-1 Omorinishi, Ota-ku, Tokyo, 143-8541, Japan.
Sengoku R; Department of Neurology, Jikei University Daisan Hospital, 4-11-1 Izumihoncho, Komae, Tokyo, 201-0003, Japan.
Yoritaka A; Department of Neurology, Juntendo University Koshigaya Hospital, 560 Fukuroyama, Koshigaya-shi, Saitama, 343-0032, Japan.
Suzuki K; Department of Neurology, Dokkyo Medical University Hospital, 880 Oaza Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan.
Nishikawa N; Department of Neurology, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, 113-8421, Tokyo, Japan.; Department of Neurology, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho, Kodaira-shi, Tokyo, 187-8551, Japan.
Mukai Y; Department of Neurology, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho, Kodaira-shi, Tokyo, 187-8551, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Kawagoe-shi, Saitama, 350-8550, Japan.
Yoshida N; Department of Neurology, Saitama Medical Center, Kawagoe-shi, Saitama, 350-8550, Japan.
Seki M; Department of Neurology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Matsukawa MK; Department of Neurology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan.
Terashi H; Department of Neurology, Tokyo Medical University Hospital, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Kimura K; Department of Neurology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama-shi, Kanagawa, 232-0024, Japan.
Tashiro J; Sapporo Parkinson MS Neurological Clinic, Dai 27 Big Sapporo-kita Sky Building 12F, 7-6 Kita-7 jo Nishi-5 chome, Kita-ku, Sapporo-shi, Hokkaido, 060-0807, Japan.
Hirano S; Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.
Murakami H; Department of Neurology, The Jikei University Hospital, 3-19-18 Nishishinbashi, Minato-ku, Tokyo, 105-8471, Japan.
Joki H; Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Uchiyama T; Department of Neurology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Naka-ku, Hamamatsu-shi, Shizuoka, 430-8558, Japan.
Shimura H; Department of Neurology, Juntendo Tokyo Koto Geriatric Medical Center, 3-3-20 Shinsuna, Koto-ku, Tokyo, 136-0075, Japan.
Ogaki K; Department of Neurology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi, Chiba, 279-0021, Japan.
Fukae J; Department of Neurology, Juntendo University Nerima Hospital, 3-1-10 Takano-dai, Nerima-ku, Tokyo, 177-8521, Japan.
Tsuboi Y; Department of Neurology, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan.
Takahashi K; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Musashidai 2-6-1, Fuchu-shi, Tokyo, 183-0042, Japan.
Yamamoto T; Department of Neurology, Saitama Medical University Hospital, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.
Yanagisawa N; Medical Technology Innovation Center, Juntendo University and Juntendo Clinical Research and Trial Center, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Nagayama H; Department of Neurology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8602, Japan.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2022 Mar 03; Vol. 22 (1), pp. 71. Date of Electronic Publication: 2022 Mar 03.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Levodopa*/adverse effects
Parkinson Disease*/drug therapy
Adenosine A2 Receptor Antagonists/pharmacology ; Adenosine A2 Receptor Antagonists/therapeutic use ; Adult ; Aged ; Aged, 80 and over ; Antiparkinson Agents/therapeutic use ; Humans ; Middle Aged ; Multicenter Studies as Topic ; Purines/pharmacology ; Purines/therapeutic use ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Utility of phrenic nerve conduction studies for identification of patients with neuromuscular diseases requiring invasive mechanical ventilation.
Autorzy:
Narukawa S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Ishizuka K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Sugimoto K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Pokaż więcej
Źródło:
Muscle & nerve [Muscle Nerve] 2022 Feb; Vol. 65 (2), pp. 211-216. Date of Electronic Publication: 2021 Nov 09.
Typ publikacji:
Journal Article
MeSH Terms:
Guillain-Barre Syndrome*/therapy
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating*
Humans ; Neural Conduction/physiology ; Neurologic Examination ; Respiration, Artificial
Czasopismo naukowe
Tytuł:
Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial I-MIBG turnover can identify Lewy body disease.
Autorzy:
Kumakura Y; Department of Diagnostic Radiology and Nuclear Medicine, Saitama Medical Center (SMC), Saitama Medical University (SMU), 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan. .
Shimizu Y; Department of Diagnostic Radiology and Nuclear Medicine, Saitama Medical Center (SMC), Saitama Medical University (SMU), 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan.
Hariu M; Department of Radiation Oncology, SMC, SMU, Kawagoe, Japan.
Ichikawa KI; Radiology Center, SMC, SMU, Kawagoe, Japan.
Yoshida N; Department of Neurology, SMC, SMU, Kawagoe, Japan.
Suzuki M; Department of Neurology, SMC, SMU, Kawagoe, Japan.
Oji S; Department of Neurology, SMC, SMU, Kawagoe, Japan.
Narukawa S; Department of Neurology, SMC, SMU, Kawagoe, Japan.
Yoshimasu H; Department of Psychiatry, SMC, SMU, Kawagoe, Japan.
Nomura K; Department of Neurology, SMC, SMU, Kawagoe, Japan.
Pokaż więcej
Źródło:
EJNMMI research [EJNMMI Res] 2021 Dec 14; Vol. 11 (1), pp. 122. Date of Electronic Publication: 2021 Dec 14.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis.
Autorzy:
Abe T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Matsuo H; The Japanese Society for Apheresis Guidelines Preparation Committee.; Former President, The Japanese Society for Apheresis.
Abe R; The Japanese Society for Apheresis Guidelines Preparation Committee.
Abe S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Asada H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ashida A; The Japanese Society for Apheresis Guidelines Preparation Committee.
Baba A; The Japanese Society for Apheresis Guidelines Preparation Committee.
Eguchi K; The Japanese Society for Apheresis Guidelines Working Group.
Eguchi Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Endo Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Fujimori Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Furuichi K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Furukawa Y; The Japanese Society for Apheresis Guidelines Working Group.
Furuya M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Furuya T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hanafusa N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hara W; The Japanese Society for Apheresis Guidelines Preparation Committee.
Harada-Shiba M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hasegawa M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hattori N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hattori M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hidaka S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hidaka T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hirayama C; The Japanese Society for Apheresis Guidelines Working Group.
Ikeda S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Imamura H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Inoue K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ishizuka K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ishizuka K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ito T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Iwamoto H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Izaki S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kagitani M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kaneko S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kaneko N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kanekura T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kitagawa K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kusaoi M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Lin Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Maeda T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Makino H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Makino S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Matsuda K; The Japanese Society for Apheresis Guidelines Working Group.
Matsugane T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Minematsu Y; The Japanese Society for Apheresis Guidelines Working Group.
Mineshima M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Miura K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Miyamoto K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Moriguchi T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Murata M; The Japanese Society for Apheresis Guidelines Working Group.
Naganuma M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Nakae H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Narukawa S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Nohara A; The Japanese Society for Apheresis Guidelines Preparation Committee.
Nomura K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ochi H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ohkubo A; The Japanese Society for Apheresis Guidelines Working Group.
Ohtake T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Okada K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Okado T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Okuyama Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Omokawa S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Oji S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sakai N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sakamoto Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sasaki S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sato M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Seishima M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Shiga H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Shimohata H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sugawara N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sugimoto K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Suzuki Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Suzuki M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Tajima T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Takikawa Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Tanaka S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Taniguchi K; The Japanese Society for Apheresis Guidelines Working Group.
Tsuchida S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Tsukamoto T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Tsushima K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ueda Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Wada T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yamada H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yamada H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yamaka T; The Japanese Society for Apheresis Guidelines Working Group.
Yamamoto K; The Japanese Society for Apheresis Guidelines Working Group.
Yokoyama Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yoshida N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yoshioka T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yamaji K; The Japanese Society for Apheresis Guidelines Preparation Committee.; President, The Japanese Society for Apheresis.
Pokaż więcej
Źródło:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy [Ther Apher Dial] 2021 Dec; Vol. 25 (6), pp. 728-876.
Typ publikacji:
Journal Article; Practice Guideline
MeSH Terms:
Blood Component Removal/*methods
Blood Component Removal/*standards
Humans ; Japan ; Societies, Medical
Czasopismo naukowe
Tytuł:
Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
Autorzy:
Tanaka S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan. Electronic address: .
Hashimoto B; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Izaki S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Fukaura H; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Pokaż więcej
Źródło:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2020 Jun; Vol. 41, pp. 102005. Date of Electronic Publication: 2020 Feb 12.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
B-Lymphocyte Subsets*
Demyelinating Autoimmune Diseases, CNS*/blood
Demyelinating Autoimmune Diseases, CNS*/cerebrospinal fluid
Demyelinating Autoimmune Diseases, CNS*/immunology
Demyelinating Autoimmune Diseases, CNS*/physiopathology
Optic Neuritis*/blood
Optic Neuritis*/cerebrospinal fluid
Optic Neuritis*/immunology
Optic Neuritis*/physiopathology
T-Lymphocyte Subsets*
Aquaporin 4/*immunology
Blood-Brain Barrier/*physiopathology
Myelin-Oligodendrocyte Glycoprotein/*immunology
Adult ; Female ; Humans ; Male ; Middle Aged ; Neuromyelitis Optica/blood ; Neuromyelitis Optica/cerebrospinal fluid ; Neuromyelitis Optica/immunology ; Neuromyelitis Optica/physiopathology
Czasopismo naukowe
Tytuł:
Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.
Autorzy:
Tahara M; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan. Electronic address: .
Oeda T; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
Okada K; Department of Neurology, University of Occupational and Environmental Health, Kitakyushu, Japan.
Kiriyama T; Department of Neurology, Nara Medical University School of Medicine, Nara, Japan.
Ochi K; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Maruyama H; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Fukaura H; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
Nomura K; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
Shimizu Y; Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Mori M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nakashima I; Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Misu T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Umemura A; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
Yamamoto K; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
Sawada H; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
Pokaż więcej
Źródło:
The Lancet. Neurology [Lancet Neurol] 2020 Apr; Vol. 19 (4), pp. 298-306. Date of Electronic Publication: 2020 Mar 18.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Aquaporin 4/*genetics
Immunologic Factors/*therapeutic use
Neuromyelitis Optica/*drug therapy
Rituximab/*therapeutic use
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Disability Evaluation ; Double-Blind Method ; Drug Therapy, Combination ; Evoked Potentials, Visual ; Female ; Humans ; Immunologic Factors/adverse effects ; Infusions, Intravenous ; Japan ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neuromyelitis Optica/diagnostic imaging ; Neuromyelitis Optica/genetics ; Prednisolone/therapeutic use ; Recurrence ; Rituximab/adverse effects ; Steroids/therapeutic use ; Treatment Outcome ; White Matter/diagnostic imaging ; Young Adult
Czasopismo naukowe
Tytuł:
Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody.
Autorzy:
Kojima M; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan. Electronic address: .
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Tanaka S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Izaki S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Hashimoto B; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Fukaura H; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Pokaż więcej
Źródło:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2019 Dec 26; Vol. 39, pp. 101907. Date of Electronic Publication: 2019 Dec 26.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement.
Autorzy:
Sugimoto K; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Neurology, Dongzhimen Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China.
Mori M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan. Electronic address: .
Liu J; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Tanaka S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Kaneko K; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology, National Hospital Organization Miyagi National Hospital, Miyagi, Japan.
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Takahashi T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology, National Hospital Organization Yonezawa National Hospital, Yonezawa, Japan.
Uzawa A; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Uchida T; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Masuda H; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Ohtani R; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Hiwasa T; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kuwabara S; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Pokaż więcej
Źródło:
Journal of neuroimmunology [J Neuroimmunol] 2019 Nov 15; Vol. 336, pp. 577021. Date of Electronic Publication: 2019 Aug 21.
Typ publikacji:
Journal Article
MeSH Terms:
Judgment*
Autoantibodies/*blood
Flow Cytometry/*standards
Myelin-Oligodendrocyte Glycoprotein/*blood
Adult ; Female ; Flow Cytometry/methods ; HEK293 Cells ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/blood ; Multiple Sclerosis/diagnosis ; Neuromyelitis Optica/blood ; Neuromyelitis Optica/diagnosis ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Intravascular large B-cell lymphoma involving large blood vessels, three autopsy cases.
Autorzy:
Sato S; Department of Hematology, Shonan Kamakura General Hospital, Kamakura, Japan.; Department of Pathology, Tokai University, School of Medicine, Isehara, Japan.
Teshima S; Department of Pathology, Shonan Kamakura General Hospital, Kamakura, Japan.
Nakamura N; Department of Pathology, Tokai University, School of Medicine, Isehara, Japan.
Ohtake T; Department of Nephrology, Immunology, and Vascular Medicine, Shonan Kamakura General Hospital, Kamakura, Japan.
Kikuchi J; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Kishi H; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.; Department of Pathology, Doai Memorial Hospital, Tokyo, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Kurose N; Department of Pathology, Kanazawa Medical University, Kanazawa, Japan.
Masaki Y; Department of Hematology and Immunology, Kanazawa Medical University, Kanazawa, Japan.
Tamaru JI; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Pokaż więcej
Źródło:
Pathology international [Pathol Int] 2019 Feb; Vol. 69 (2), pp. 97-103. Date of Electronic Publication: 2019 Jan 23.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lymphoma, Large B-Cell, Diffuse/*pathology
Vascular Neoplasms/*pathology
Aged ; Female ; Humans ; Male ; Middle Aged ; Neoplastic Cells, Circulating/pathology
Czasopismo naukowe
Tytuł:
Mean Platelet Volume Is Associated with Early Neurological Deterioration in Patients with Branch Atheromatous Disease: Involvement of Platelet Activation.
Autorzy:
Oji S; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan. Electronic address: .
Tomohisa D; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Hara W; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Tajima T; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Suzuki M; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Saito A; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Yoshida N; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Nomura K; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Pokaż więcej
Źródło:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2018 Jun; Vol. 27 (6), pp. 1624-1631. Date of Electronic Publication: 2018 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
Mean Platelet Volume*
Platelet Activation*
Brain Ischemia/*blood
Stroke/*blood
Adult ; Aged ; Aged, 80 and over ; Area Under Curve ; Brain Ischemia/diagnosis ; Brain Ischemia/physiopathology ; Brain Ischemia/therapy ; Disability Evaluation ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; ROC Curve ; Retrospective Studies ; Risk Factors ; Stroke/diagnosis ; Stroke/physiopathology ; Stroke/therapy ; Time Factors
Czasopismo naukowe
Tytuł:
Guillain-Barré syndrome initially manifesting as motor weakness, urinary dysfunction and hyperreflexia: Case report and literature review.
Autorzy:
Oji, Satoru
Narukawa, Shinya
Ishizuka, Keita
Sugimoto, Kohei
Yoshida, Norihito
Takeshita, Hideki
Kaida, Ken‐ichi
Nomura, Kyoichi
Pokaż więcej
Źródło:
Clinical & Experimental Neuroimmunology. May2018, Vol. 9 Issue 2, p110-114. 5p.
Czasopismo naukowe
Tytuł:
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Autorzy:
Achiron, Anat
Achtnichts, Lutz
Agan, Kadriye
Akman-Demir, Gulsen
Allen, Alison B
Antel, Jack P
Antiguedad, Alfredo Rodriguez
Apperson, Michelle
Applebee, Angela M
Ayuso, Guillermo Izquierdo
Baba, Masayuki
Bajenaru, Ovidiu
Balasa, Rodica
Balci, Belgin Petek
Barnett, Michael
Bass, Ann
Becker, Veit U
Bejinariu, Mihaela
Bergh, Florian Then
Bergmann, Arnfin
Bernitsas, Evanthia
Berthele, Achim
Bhan, Virender
Bischof, Felix
Bjork, Randall John
Blevins, Gregg
Boehringer, Matthias
Boerner, Thomas
Bonek, Robert
Bowen, James D
Bowling, Allen
Boyko, Alexey N
Boz, Cavit
Bracknies, Vera
Braune, Stefan
Brescia Morra, Vincenzo
Brochet, Bruno
Brola, Waldemar
Brownstone, Paul Kenneth
Brozman, Miroslav
Brunet, Donald
Buraga, Ioan
Burnett, Margaret
Buttmann, Mathias
Butzkueven, Helmut
Cahill, Jonathan
Calkwood, Jonathan C
Camu, William
Cascione, Mark
Castelnovo, Giovani
Centonze, Diego
Cerqueira, Joao
Chan, Andrew
Cimprichova, Andrea
Cohan, Stanley
Comi, Giancarlo
Conway, Jill
Cooper, Joanna A
Corboy, John
Correale, Jorge
Costell, Brian
Cottrell, David A
Coyle, Patricia K
Craner, Matthew
Cui, Liying
Cunha, Luis
Czlonkowska, Anna
da Silva, Ana Martins
de Sa, Joao
de Seze, Jérôme
Debouverie, Marc
Debruyne, Jan
Decoo, Danny
Defer, Gilles
Derfuss, Tobias
Deri, Norma H
Dihenia, Bhupesh
Dioszeghy, Peter
Donath, Vladimir
Dubois, Benedicte
Duddy, Martin
Duquette, Pierre
Edan, Gilles
Efendi, Husnu
Elias, Stanton
Emrich, Peter J
Estruch, Bonaventura Casanova
Evdoshenko, Evgeniy P
Faiss, Juergen
Fedyanin, Alexander S
Feneberg, Wolfgang
Fermont, Jiske
Fernandez, Oscar Fernandez
Ferrer, Francisco Coret
Fink, Katharina
Ford, Helen
Ford, Corey
Francia, Ada
Freedman, Mark
Frishberg, Benjamin
Galgani, Simonetta
Garmany, George P
Gehring, Klaus
Gitt, Jeffrey
Gobbi, Claudio
Goldstick, Lawrence P
Gonzalez, Rafael Arroyo
Grandmaison, Francois
Grigoriadis, Nikolaos
Grigorova, Olga
Grimaldi, Luigi Maria Edoardo
Gross, Jeffrey
Gross-Paju, Katrin
Gudesblatt, Mark
Guillaume, Daniel
Haas, Judith
Hancinova, Viera
Hancu, Anca
Hardiman, Orla
Harmjanz, Arndt
Heidenreich, Fedor R
Hengstman, G J D
Herbert, Joseph
Herring, Mark
Hodgkinson, Suzanne
Hoffmann, Olaf M
Hofmann, Werner E
Honeycutt, William D
Hua, Le Hanh
Huang, Dehui
Huang, Yining
Huang, DeRen
Hupperts, Raymond
Imre, Piroska
Jacobs, Alan Keith
Jakab, Gabor
Jasinska, Elzbieta
Kaida, Kenichi
Kalnina, Jolanta
Kaprelyan, Ara
Karelis, Guntis
Karussis, Dimitrios
Katz, Amos
Khabirov, Farit A
Khatri, Bhupendra
Kimura, Takashi
Kister, Ilya
Kizlaitiene, Rasa
Klimova, Eleonora
Koehler, Juergen
Komatineni, Aparna
Kornhuber, Anselm
Kovacs, Krisztina
Koves, Agnes
Kozubski, Wojciech
Krastev, Georgi
Krupp, Lauren B
Kurca, Egon
Lassek, Christoph
Laureys, Guy
Lee, Liesly
Lensch, Eckart
Leutmezer, Fritz
Li, Hongzeng
Linker, Ralf A
Linnebank, Michael
Liskova, Petra
Llanera, Cristina
Lu, Jiahong
Lutterotti, Andreas
Lycke, Jan
Macdonell, Richard
Maciejowski, Maciej
Maeurer, Mathias
Magzhanov, Rim V
Maida, Eva-Maria
Malciene, Lina
Mao-Draayer, Yang
Marfia, Girolama Alessandra
Markowitz, Clyde
Mastorodimos, Vasileios
Matyas, Klotild
Meca-Lallana, Jose
Merino, Juan Antonio Garcia
Mihetiu, Ioan Gheorghe
Milanov, Ivan
Miller, Aaron E
Millers, Andrejs
Mirabella, Massimiliano
Mizuno, Masanori
Montalban, Xavier
Montoya, Lilina
Mori, Masahiro
Mueller, Stefanie
Nakahara, Jin
Nakatsuji, Yuji
Newsome, Scott
Nicholas, Richard
Nielsen, A Scott
Nikfekr, Esmaeil
Nocentini, Ugo
Nohara, Chiyoko
Nomura, Kyoichi
Odinak, Miroslav M
Olsson, Tomas
van Oosten, B W
Oreja-Guevara, Celia
Oschmann, Patrick
Overell, James
Pachner, Andrew
Panczel, Gyula
Pandolfo, Massimo
Papeix, Caroline
Patrucco, Liliana
Pelletier, Jean
Piedrabuena, Raul
Pless, Misha
Polzer, Udo
Pozsegovits, Krisztian
Rastenyte, Daiva
Rauer, Sebastian
Reifschneider, Gerd
Rey, Roberto
Rizvi, Syed A
Robertson, Derrick
Rodriguez, Jose Martinez
Rog, David
Roshanisefat, Homayoun
Rowe, Vernon
Rozsa, Csilla
Rubin, Susan
Rusek, Stanislaw
Saccà, Francesco
Saida, Takahiko
Salgado, Antonio Vasco
Sanchez, Victoria Eugenia Fernandez
Sanders, Kalina
Satori, Maria
Sazonov, Denis V
Scarpini, Elio Angelo
Schlegel, Eugen
Schluep, Myriam
Schmidt, Stephan
Scholz, Erich
Schrijver, H M
Schwab, Matthias
Schwartz, Raymond
Scott, James
Selmaj, Krzysztof
Shafer, Stuart
Sharrack, Basil
Shchukin, Ivan A
Shimizu, Yuko
Shotekov, Penko
Siever, Arno
Sigel, Karl-Otto
Silliman, Scott
Simo, Magdolna
Simu, Mihaela
Sinay, Vladimiro
Siquier, Antonio Escartin
Siva, Aksel
Skoda, Ondrej
Solomon, Andrew
Stangel, Martin
Stefoski, Dusan
Steingo, Brian
Stolyarov, Igor D
Stourac, Pavel
Strassburger-Krogias, Katrin
Strauss, Erik
Stuve, Olaf
Tarnev, Ivaylo
Tavernarakis, Antonios
Tello, Cristina Ramo
Terzi, Murat
Ticha, Veronika
Ticmeanu, Marina
Tiel-Wilck, Klaus
Toomsoo, Toomas
Tubridy, Niall
Tullman, Mark J
Tumani, Hayrettin
Turcani, Peter
Turner, Ben
Uccelli, Antonio
Urtaza, Francisco Javier Olascoaga
Vachova, Marta
Valikovics, Attila
Walter, Silke
Van Wijmeersch, Bart
Vanopdenbosch, Ludo
Weber, Joerg R
Weiss, Sara
Weissert, Robert
Vermersch, Patrick
West, Timothy
Wiendl, Heinz
Wiertlewski, Sandrine
Wildemann, Brigitte
Willekens, Barbara
Visser, L H
Vorobeychik, Galina
Xu, Xianhao
Yamamura, Takashi
Yang, Yi N
Yelamos, Sergio Martinez
Yeung, Michael
Zacharias, Alan
Zelkowitz, Marvin
Zettl, Uwe
Zhang, Meini
Zhou, Hongyu
Zieman, Ulf
Ziemssen, Tjalf
Kappos, Ludwig
Pokaż więcej
Źródło:
In The Lancet 31 March-6 April 2018 391(10127):1263-1273
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz